# Medly

> Medly was a New York digital pharmacy combining local dispensaries, pharmacist support, insurance coordination and free same-day prescription delivery. Founded in 2017, it expanded through Pharmaca before filing for bankruptcy in December 2022. Walgreens bought selected pharmacy assets in 2023; Medly ceased operations. Former executives subsequently faced SEC fraud allegations.

- **Founded:** 2017
- **Headquarters:** New York, United States
- **Founders:** Marg Patel (Co-founder and former CEO), Sahaj Patel (Co-founder), Chirag Kulkarni (Co-founder and former Chief Marketing Officer)
- **Products:** Prescription dispensing and delivery, Digital prescription management, Insurance and affordability assistance, Pharmaca wellness retail
- **Notable:** Raised an announced $100 million Series B in July 2020., Reported more than 500,000 prescriptions delivered by July 2020., Pharmaca acquisition expanded its physical footprint toward almost 30 markets in 2021.

## Products & services

- **Prescription dispensing and delivery** — Retail and specialty prescriptions dispensed from local pharmacies with free same-day delivery in supported markets; discontinued.
- **Digital prescription management** — App and web tools for prescription management, pharmacist communication and delivery scheduling or tracking; discontinued.
- **Insurance and affordability assistance** — Staff helped coordinate prior authorizations, insurance claims and available copay or manufacturer assistance.
- **Pharmaca wellness retail** — Acquired chain added vitamins, supplements, nonprescription medicines and beauty products.

## Achievements

- Raised an announced $100 million Series B in July 2020.
- Reported more than 500,000 prescriptions delivered by July 2020.
- Pharmaca acquisition expanded its physical footprint toward almost 30 markets in 2021.

## Latest updates

- **2023-02** — Bankruptcy sale of selected pharmacy assets to Walgreens for $19.35 million approved; remaining operations closed.
- **2023-04** — Cases converted to Chapter 7 on April 25, according to Epiq.
- **2024-09** — SEC sued former executives Marg Patel, Robert Horowitz and Chintankumar Bhatt, alleging fraudulent financial reporting in fundraising.
- **2025-07** — Court denied Bhatt’s dismissal motion and largely denied Horowitz’s, while dismissing scheme-liability claims against Horowitz. This was a pleading-stage decision, not a fraud verdict.

## Links

- Website: https://www.medlypharmacy.com/
- LinkedIn: https://www.linkedin.com/company/medly/
- Twitter/X: https://twitter.com/medlypharmacy
- Instagram: https://www.instagram.com/medlypharmacy/
- Facebook: https://www.facebook.com/MedlyPharmacy

---

Profile page: https://yespress.io/medly
Published by YesPress — https://yespress.io
Last updated: 2026-10-24